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CASE PRESENTATION
A 64-year-old man was referred to our hospital because of
acute renal failure of unknown etiology; he had a 2-week
history of intermittent fever, chills, easy fatigue, cough,
and exertional dyspnea. In addition, he reported
generalized edema and a weight gain of 6 kg over 1
month. The past medical history was remarkable for
pulmonary tuberculosis treated 15 years earlier and
previous tobacco abuse. The patient denied recent travel,
exposure to animals, and medications; he had been
generally healthy without systemic disease, including
diabetes and hypertension. Six months before
presentation, a routine medical evaluation at a local
hospital showed that he had no health problems.
On admission the physical examination showed a body
temperature of 37.8 1C, the blood pressure was 110/
70mmHg, the pulse rate was 110 beats/min, and the
respiratory rate was 28 breaths/min. There were no signs or
symptoms indicating a neurological disorder. There was no
palpable regional lymphadenopathy or abnormally pigmen-
ted skin lesions. Coarse inspiratory crackles were audible
bilaterally over the basal lung fields. The abdomen was flat
and soft without organomegaly. However, tenderness was
noted at both costovertebral angles. In addition, there was
pitting edema of both lower legs. The urine dipstick test was
positive for protein (2þ ), with leukocyturia and microscopic
hematuria on microscopic examination; the 24-h urine
collection had 810mg of protein. The other biochemical
values are summarized in Table 1. All viral markers were
negative, including hepatitis B surface antigen, hepatitis C
antibody, cytomegalovirus immunoglobulin M antibody,
herpes simplex immunoglobulin M antibody, human im-
munodeficiency virus (HIV), and hantavirus antibody. An
initial chest X-ray showed no active lung lesions, except for
fibrocalcified opacities at both upper lung fields. The renal
ultrasound revealed enlargement of both kidneys with
normal corticomedullary differentiation, suggesting acute
renal parenchymal disease.
The patient was treated with intravenous fluid adminis-
tration and empirical antibiotics for presumed acute bilateral
bacterial pyelonephritis. The initial and follow-up cultures of
the blood, urine, and sputum revealed no organisms. Despite
a change of the antibiotics later, the pyuria persisted, the
leukocytosis worsened over the following days, and the serum
creatinine increased up to 4.26mg/100ml. The worsening
azotemia and newly developed pulmonary edema required
hemodialysis. Additional laboratory data including serologies
were normal: negative antinuclear antibodies, negative
antineutrophilic cytoplasmic antibodies, negative cryoglobu-
lins, and normal complements levels. There was no sign of
disseminated intravascular coagulation by tests of the clotting
and fibrinolytic systems. The serum and urine protein
electrophoresis revealed a slight acute phase response and
the urine test for the Bence Jones protein was negative. A
computerized tomographic scan of the abdomen and pelvis
showed marked increase in the size of both kidneys (the left
was 14.7 cm and the right 17.0 cm in length) with diffusely
decreased enhancement, but gave no additional information
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(Figure 1). We considered initially that the acute renal failure
was because of a bacterial pyelonephritis or a renal abscess.
However, there was no evidence of a specific infection from
the biochemical studies or the culture results. The renal
function of the patient continued to worsen without response
to the antibiotics. A rapidly progressive glomerulonephritis
was thought to be the probable diagnosis. A renal biopsy was
performed to ascertain the etiology of the acute renal failure.
RENAL BIOPSY FINDINGS
Light microscopic examination disclosed one core of cortex
containing only two glomeruli, which were not sclerotic. The
renal tubules showed atrophic changes. The interstitium was
markedly infiltrated by abundant mononuclear cells and
neutrophils with noncaseating granulomas (Figure 2a). There
was a mild degree of interstitial fibrosis. The immunofluor-
escent studies were negative for immunoglobulins and
complements. Special stains for microorganisms were
performed to exclude infectious etiologies. Periodic acid-
Schiff (PAS) and silver methenamine revealed a few scattered
fungal yeast-like organisms within the cortical interstitium
(Figure 2b). Although the etiology of the yeast forms could be
not identified, a presumptive diagnosis of granulomatous
interstitial nephritis (GIN) due to a fungal infection was
made based on the renal pathological findings. Treatment
with oral fluconazole, 200mg/day orally, was started. Because
the first biopsy was an insufficient specimen, for clarification
Table 1 | Laboratory data at presentation
Blood test (unit) Reference range On admission
White blood count ( 109/l) 5.0–10.0 7.4
Hemoglobin (g/100ml) 14–18 11.8
Hematocrit (%) 42–52 33.7
Platelet ( 109/l) 150–450 36
ESR (mm/h) 0–10 120
CRP (mg/l) o5 184.19
Sodium (mmol/l) 135–148 132
Potassium (mmol/l) 3.5–5.1 6.6
Chloride (mmol/l) 98–108 97
Blood urea nitrogen (mg/100ml) 8–23 96.2
Creatinine (mg/100ml) 0.5–1.2 3.98
Glucose (mg/100ml) 60–110 72
Total protein (g/100ml) 6.7–8.3 5.68
Albumin (g/100ml) 3.8–5.3 2.62
AST (IU/l) 13–36 41
ALT (IU/l) 5–40 31
Creatinine phosphokinase (IU/l) 26–400 40
ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive
protein; ESR, erythrocyte sedimentation rate.
Figure 1 |An abdominal computed tomography (CT) of the
kidneys shows marked enlargement of both kidneys.
Figure 2 |Representative microphotographs of the first renal
biopsy from the patient. Low-power view shows interstitial
inflammation and granulomatous changes (a; original
magnification  200, hematoxylin and eosin). High-power view
(b; original magnification  400, PAS) reveals several interstitial
yeast forms (arrowhead). The yeast (arrowhead) stained positively
for Fontana-Masson silver (c; original magnification  400,
Fontana-Masson silver).
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of the etiology of the fungal infection, a repeat renal biopsy
was performed. The light microscopy confirmed the findings
of the first biopsy. The yeast forms were negative for Alcian
blue and mucicarmine stains, but they were positive for the
Fontana-Masson stain (Figure 2c), suggesting a capsule-
deficient cryptococcal infection.
CLINICAL FOLLOW-UP
The serially repeated results of the serum cryptococcal
antigen test were negative. With the continued administra-
tion of fluconazole, the renal function recovered slowly in
association with an improved general condition (Figure 3).
At discharge, in September 2004, the creatinine level was
1.78mg/100ml. In May 2005, 4 months after cessation of 6
months of fluconazole therapy, a post-treatment renal biopsy
was performed to determine why the renal function did not
return to normal. The light microscopic examination showed
that 10 of 90 glomeruli had global sclerosis and all of the
others had segmental sclerosis. The renal tubules showed
marked atrophic changes with no frank necrosis. A moderate
degree of mononuclear cell infiltration and marked fibrotic
changes were seen in the interstitium (Figure 4). The special
stains were all negative. In August 2006, at the last visit to our
clinic the patient was doing well except for the elevation of
his creatinine to 2.98mg/100ml.
DISCUSSION
A granulomatous inflammatory response is ubiquitous in
pathology; it is a manifestation of many infectious, toxic,
allergic, autoimmune, and neoplastic diseases as well as
conditions of unknown etiology.1,2 Recognition of the
characteristics of the granuloma with regard to its etiology,
degradability, and immunogenicity is important for patient
management.2 In the field of renal pathology, granuloma
formation can be encountered in the limited setting of acute
interstitial nephritis. For example, in the report by Viero and
Cavallo,3 granulomas were detected in only 12 cases
(incidence: 5.9%) of 203 renal biopsies during a 20-year
period; Bijol et al.4 identified 46 cases (0.5%) of GIN over a
17-year period at a single institution. Recently, Joss et al.5 also
reported their experience with only 18 patients (o1%)
among their renal biopsies during a 15-year period. The
cause of GIN varies. Among the more common causes are
drugs and sarcoidosis; approximately 25–45% of cases with
GIN are drug induced.3,4 The medications that are commonly
implicated are antibiotics, nonsteroidal anti-inflammatory
drugs, allopurinol, and diuretics, as shown in Table 2. In
addition to drugs, other agents or conditions commonly
associated with GIN include infections, allergies, autoim-
mune, and neoplastic disorders and in some cases the
etiology is idiopathic.
The pathogenic mechanism underlying GIN is poorly
understood. However, evidence derived from various
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Figure 3 |Clinical course of the patient. Serum creatinine level
decreases slowly after fluconazole treatment but does not return
to completely normal (Bx, renal biopsy; HD, hemodialysis).
Figure 4 |Representative microphotograph of the post-
treatment renal biopsy from the patient. A marked degree of
interstitial fibrosis with mononuclear cell infiltration and tubular
atrophy is shown, consistent with chronic interstitial nephritis
(original magnification  200, PAS).
Table 2 | Causes of granulomatous interstitial nephritis
Cause Reference
Drug
BCG, intravesical 4,6
Antibiotics (ampicillin, vancomycin, cefuroxime,
clarithromycin, fluoroquinolone, rifampin, etc.)
5,7–11
NSAIDs 5,11
Diuretics (thiazide) 5,11
Allopurinol 5,12
Anticonvulsant (lamotrigine) 5,16
Omeprazole 13
Bisphosphonate 14
All-trans retinoic acid 15
Heroin abuse 17
Infection
Bacteria (E. coli, rhodococcus, etc.) 3,11,18,19
Mycobacterium tuberculosis 11
Virus (adenovirus, HIV, etc.) 20–22
Fungus (histoplasma, candida, cryptococcus, etc.) 11,23–25
Inflammatory or systemic condition
Sarcoidosis 3,4,5
Wegener’s granulomatosis 3,5
Tubulointerstitial nephritis and uveitis syndrome 5
Crohn’s disease 26
Hematologic malignancy (leukemia, multiple myeloma) 27
Idiopathic 5,28
BCG, Bacille Calmette-Guerin; HIV, human immunodeficiency virus; NSAIDs,
nonsteroidal anti-inflammatory drugs.
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observations suggests a T-cell-mediated reaction.2,3 The
predominance of mononuclear cells in the interstitial
infiltrates, the presence of mostly T cells, the presence of
granulomas, and the absence of immunoglobulin deposition
in the tubules or interstitium support a T-cell-mediated
mechanism.3 Because GIN occurs with diverse conditions,
the mechanisms of tissue injury and/or the components of
the granuloma can also vary. When GIN is infection related,
there is an abundance of neutrophils, which predominates
over all other cell types, although in such biopsies the
number of T cells, macrophages, and B cells is also impressive
and consistent with the findings of biopsies from drug- and
sarcoid-related granulomatous GIN.3 Infection-related GIN
accounts for only a small percentage of cases, about 6.7%
of the total number of cases from the three largest
series reported.4,5,23 Mycobacteria and fungi are the
main etiologies of the infectious causes and account for
most cases of infectious GIN in renal transplants.3,5 GIN
secondary to fungal infection, mainly with the Histoplasma
and Candida species, has been described in a few cases,3,23–25
primarily in patients who are immunocompromised. In
the case presented here we identified another fungal
infection, Cryptococcus, as a cause of GIN in an immuno-
competent host.
The encapsulated yeast, Cryptococcus species, is a major
opportunistic fungal pathogen that is recognized world-
wide.29 More than 30 species are included in the genus
Cryptococcus. The pathogenic yeasts of Cryptococcus cur-
rently consist of two species: C. neoformans and C. gatti.
In the environment, C. neoformans is primarily found
worldwide in association with the excrement of certain birds,
such as pigeons and tree hollows. C. gatti has been found
primarily in tropical and subtropical regions. However, more
currently, there has been unprecedented emergence of these
isolates on Vancouver Island since 1999, demonstrating that
the distribution and ecology of this organism is now
changing; it is now associated with a wide range of trees,
such as firs and oaks.30 The specific source of the infection
and the form responsible for human infections have not been
definitely established. Direct evidence for human infection
from either eucalyptus trees or pigeon excrement has not
been established. However, it is recommended that indivi-
duals at risk for Cryptococcus avoid sites that are
contaminated with pigeon excrement and avoid having
certain birds, such as pigeons, canaries, and cockatoos,
as pets.30
In general, cryptococcal infection is an uncommon
systemic fungal infection that occurs primarily in patients
who have impaired immunity, such as patients with
hematologic malignancies, organ transplants, and those
taking systemic corticosteroids or other immunosuppres-
sants. Since the epidemic of HIV infections, Cryptococcus
has become an important opportunistic infection in HIV-
infected individuals; as a result its incidence has increased
dramatically.30,31Solid organ transplant recipients are
also recognized to be at increased risk for Cryptococcus
infections. Current estimates suggest that 20–60% of the cases
with Cryptococcus infections, that are HIV negative, occur in
organ transplant recipients.32,33 Although renal transplant
recipients have been thought to have the lowest incidence of
fungal infection compared with other organ transplants,
3.5–5% of infections, in renal transplant recipients, are due to
fungi,34,35 and among the fungal infections, Cryptococcus is
the third most common in renal transplant recipients after
candida and aspergillus, as well as in all solid organ
transplant recipients.35,36 More importantly, despite the
initiation of therapy, the mortality rate associated with this
infection, in this patient population, remains high.32 In
addition to patients with renal transplants, nephrologists
encounter cryptococcal infections in patients treated with
immunosuppressive agents, those have renal failure37,38 or on
dialysis.39 Patients on dialysis have a nearly 10-fold increased
risk for hospitalizations resulting from fungal infections
compared to the general population.39 Of the leading
etiologies of fungal infections in dialysis patients, Crypto-
coccus (6%) has been reported to be the second most
common after candida (79%).39 Because patients with
chronic renal failure and patients on maintenance dialysis
therapy have been shown to have a wide range of immune
deficiencies and increased risk for infection following
instrumentation, it is not surprising that this patient
population has an increased risk for being hospitalized for
fungal infections including Cryptococcus.38,39
The central nervous system and respiratory tract are the
most common organs involved in cryptococcal infection. In a
review of non-HIV-infected patients, 36% of cases had only
pulmonary involvement, 51% of cases had central nervous
system disease, and the remainder had other or multiple sites
of infection.31 In fact, this yeast can cause disease in every
organ of the human body, including skin, eyes, bone, blood,
prostate, and the urinary tract.30 Cryptococcus enters the
body through the lungs, the most common portal of entry
for infection, and becomes disseminated hematologically
with a predilection for the central nervous system and skin
and less frequently to other sites such as the urinary tract and
kidneys.30,32,33 Most cases with Cryptococcus of the kidneys
have disseminated disease in immunocompromised hosts;
generally the infection begins in the lungs and spreads to the
brain and meninges.40–44 Reviews of patients with dissemi-
nated Cryptococcus have demonstrated renal involvement in
26–51.2% of cases.34,42 There may be signs and symptoms of
cystitis, pyuria, hematuria, moderate proteinuria, and
laboratory evidence of renal insufficiency.44 The character-
istic lesion in the kidney is a non-suppurating granuloma.41
The fungi spread through the blood stream and lodge within
the glomeruli where they can form abscesses followed by
granulomatous inflammation.40 A caseous appearance is
sometimes produced by the widespread death of the
cryptococci, possibly due to the development of hypersensi-
tivity host responses.40,41 Cortical and medullary abscesses,
caseation necrosis and interstitial inflammation, fibrosis, and
papillary necrosis have also been noted.43,44 However,
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without such characteristic lesions, only extensive necrosis
and suppuration may be present.41 The histopathological
features may vary according to the immune status of the
infected host. In an immunocompetent individual, a typical
granuloma is usually observed at the site of the cryptococcal
infection. However, no purulent inflammatory responses are
usually observed in the cryptococcal lesions of AIDS
patients.45 Granulomatous inflammation, like any inflam-
matory reaction, frequently results in tissue damage during
the active phase and fibrosis during the healing process.1,5
Granulomas can resolve but are often replaced by scar tissue.
This is the likely explanation for the renal function not
returning to normal in our patient.
The treatment of choice for Cryptococcus depends on the
anatomical site of involvement and the host’s immune status.
The guidelines published by the Infectious Disease Society of
America provide recommendations for clinicians and can be
used at the beginning of treatment to guide clinical decisions
for patients with Cryptococcus infections. However, the
guidelines are not absolute or definitive and a given specific
clinical situation may demand creative management.29
Treatment strategies for Cryptococcus of the kidney vary.
Randal et al.44 treated one case with intravenous amphoter-
icin B in daily doses of 20–30mg for 38 days in a total
amount of 1 g and the patient improved clinically. In a case of
cryptococcal pyelonephritis and disseminated Cryptococcus,
in a renal transplant recipient, the therapy included
amphotericin B, 0.3mg/kg/day and flucytosine, 60mg/kg/
day for 4 weeks; this treatment did not eradicate the
Cryptococcus from the kidney and was associated with
hepatotoxicity.43 In another case of a renal allograft infection,
the patient continued intravenous amphotericin B lipid
complex 400mg q.d. and flucytosine 3 g p.o. q.d. for 1
month.34 In our patient, fluconazole 200mg p.o. q.d. for 6
months was planned without amphotericin B induction
therapy. Treatment with oral fluconazole was followed by a
prolonged remission, as was confirmed by the follow-up
biopsy.
To summarize, we demonstrate here that an immuno-
competent patient had an unusual cryptococcal GIN, which
was treated successfully with fluconazole. This is the first
report of GIN due to Cryptococcus without disseminated
disease in a host that was not immunocompromised.
Although a renal infection is a relative contraindication to
a renal biopsy, a pathological work-up with special stains of
the renal biopsy tissue helps in the differential diagnosis of a
patient with worsening renal failure of unknown etiology.
Failure to recognize GIN due to Cryptococcus and initiate
the appropriate treatment may lead to an irreversible renal
outcome or even a fatal result. When properly recognized and
treated, recovery from GIN is possible but the possibility of
post-inflammatory renal impairment requires continued
monitoring.
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